Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (271-280 of 374) with videos related to

Pageof 38
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in MedicareHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2012
Association between anti-TNF-α therapy and all-cause mortalityLisa J Herrinton, Liyan Liu, Lang Chen, et al.
Clinical and Translational Science|December 21, 2012
Preliminary competencies for comparative effectiveness researchJodi B Segal, Wishwa Kapoor, Timothy Carey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or TeriparatideKenneth G Saag, Donato Agnusdei, Didier Hans, et al.
Annals of the Rheumatic Diseases|August 8, 2020
SARS CoV-2 infection among patients using immunomodulatory therapiesKevin L Winthrop, Amanda E Brunton, Susan Beekmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settingsStephanie S Ledbetter, Fenglong Xie, Gary Cutter, et al.
Archives of Internal Medicine|March 29, 2007
Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trialJeffrey R Curtis, Andrew O Westfall, Jeroan Allison, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two yearsSydney Bonnick, Kenneth G Saag, Douglas P Kiel, et al.
Arthritis and Rheumatism|March 6, 2013
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
Journal of the National Medical Association|September 22, 2005
Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative dataTed R Mikuls, Kenneth G Saag, Jeffrey Curtis, et al.
Pageof 38

Showing results (271-280 of 374) with videos related to

Sort By:
Pageof 38
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in MedicareHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2012
Association between anti-TNF-α therapy and all-cause mortalityLisa J Herrinton, Liyan Liu, Lang Chen, et al.
Clinical and Translational Science|December 21, 2012
Preliminary competencies for comparative effectiveness researchJodi B Segal, Wishwa Kapoor, Timothy Carey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or TeriparatideKenneth G Saag, Donato Agnusdei, Didier Hans, et al.
Annals of the Rheumatic Diseases|August 8, 2020
SARS CoV-2 infection among patients using immunomodulatory therapiesKevin L Winthrop, Amanda E Brunton, Susan Beekmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settingsStephanie S Ledbetter, Fenglong Xie, Gary Cutter, et al.
Archives of Internal Medicine|March 29, 2007
Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trialJeffrey R Curtis, Andrew O Westfall, Jeroan Allison, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two yearsSydney Bonnick, Kenneth G Saag, Douglas P Kiel, et al.
Arthritis and Rheumatism|March 6, 2013
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
Journal of the National Medical Association|September 22, 2005
Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative dataTed R Mikuls, Kenneth G Saag, Jeffrey Curtis, et al.
Pageof 38